Search

everythinglearnresearchcommunity

for

Search:↓

TBX5 gene influences feathered feet in Guangxi chickens by affecting cell growth and movement.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

PBM helps improve cell survival in 3D tissue engineering.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

People with telogen effluvium and scalp discomfort might have low vitamin B12 and could benefit from B12 supplements.

People with Birt-Hogg-Dubé syndrome often have lung problems and delayed diagnosis, and better recognition of CT scan signs could improve diagnosis and management.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.

TCDD changes skin cell growth and keratin production in mice.

Thymosin beta-4 promotes hair growth in mice.

A baby's toe was severely damaged by a hair tourniquet, leading to bone and tendon damage, but improved after surgery and treatment.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

Some children in Malaysia with symptoms have either profound or partial biotinidase deficiency, and early testing and treatment are important.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

β-interferon injections for melanoma can cause excessive hair growth at the injection sites.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Two sisters had a rare hair condition without other usual symptoms.

Gene expression in milk cells and blood can help detect illegal rbST use in cows.

BST2 is a key marker for hair loss disease alopecia areata.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.